Clinical Trial Update: Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of a novel malathion formulation for treating head lice has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head Lice Infestation

Drugs mentioned

• Malathion (novel formulation) (malathion)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Lice Infestations | Phase 3 | Status: COMPLETED